Evidence map›Paper›PMID 41294034›Full record

ArticleeLife2025

SMC5/6-mediated plasmid silencing is directed by SIMC1-SLF2 and antagonized by the SV40 large T antigen.

Martina Oravcová, Minghua Nie, Takanori Otomo, Michael N Boddy

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Epigenetic regulation of transgenes.Journal of biotechnology · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Martina OravcováDepartment of Molecular and Cellular Biology, The Scripps Research Institute, San Diego, United States.ORCID https://orcid.org/0000-0001-6063-2227
Minghua NieDepartment of Molecular and Cellular Biology, The Scripps Research Institute, San Diego, United States.
Takanori OtomoSan Diego Biomedical Research Institute, San Diego, United States.ORCID https://orcid.org/0000-0003-3589-238X
Michael N BoddyDepartment of Molecular and Cellular Biology, The Scripps Research Institute, San Diego, United States.ORCID https://orcid.org/0000-0001-7618-4449

Funding

Structural Studies of the Autophagic Ubiquitin-Like ProteinsR01GM092740 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI OTOMO, TAKANORI · 2011 to 2023
$5.9M
Defining Genome Stability Mechanisms and their Regulation by SUMO and UbiquitinR35GM136273 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI MICHAEL N BODDY · 2020 to 2026
$4.3M
NIGMS NIH HHS GM092740NIGMS NIH HHS R01 GM092740NIGMS NIH HHS R35 GM136273
6 · The paper itself

Abstract

SMC5/6 is unique among the Structural Maintenance of Chromosomes (SMC) complexes in its ability to repress transcription from extrachromosomal circular DNA (ecDNA), including viral genomes and plasmids. Previously, we showed that human SMC5/6 is regulated by two mutually exclusive subcomplexes-SIMC1-SLF2 and SLF1/2-the counterparts of yeast Nse5/6 (Oravcová et al., 2022). Notably, only SIMC1-SLF2 recruits SMC5/6 to SV40 large T antigen (LT) foci in PML nuclear bodies (PML NBs), suggesting that these regulatory subcomplexes direct distinct roles of SMC5/6 on chromosomal versus ecDNA. However, their roles in plasmid repression remain unclear. Here, we demonstrate that SMC5/6-mediated repression of plasmid transcription depends exclusively on SIMC1-SLF2, whereas SLF1/2 is dispensable. Reinforcing its specialized role in ecDNA suppression, SIMC1-SLF2 does not participate in SMC5/6 recruitment to chromosomal DNA lesions. We further show that plasmid silencing requires a conserved interaction between SIMC1-SLF2 and SMC6, mirroring the functional relationship observed between yeast Nse5/6 and Smc6. As for viral silencing, plasmid repression depends on the SUMO pathway; however, unlike viral silencing, it does not require PML NBs. Additionally, we find that LT interacts with SMC5/6 and increases plasmid transcription to levels observed in SIMC1-SLF2-deficient cells-echoing the antagonistic roles of HBx (HBV) and Vpr (HIV-1) in viral genome repression. These findings expand the paradigm of viral antagonism against SMC5/6-mediated silencing, positioning LT as a novel player in this evolutionary tug-of-war.

Indexed as

Cell Cycle ProteinsGene SilencingPlasmidsRepressor ProteinsChromosomal Proteins, Non-HistoneHumansCell Cycle ProteinsChromosomal Proteins, Non-HistoneRepressor ProteinsSMC5 protein, humanSMC6 protein, humancell biologycomplex structureDNA repairhumaninnate immunitySIMC1SLF2SMC5/6

Identifiers

PMID41294034
PMCPMC12656486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.